首页> 外文期刊>Bone marrow transplantation >A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT.
【24h】

A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT.

机译:对非清髓性造血SCT成人患者急性肾损伤的多中心回顾性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Acute kidney injury (AKI) is a common early complication in patients with hematopoietic SCT (HSCT). However, there are limited data about the incidence and risk factors of AKI in patients with nonmyeloablative HSCT. We conducted a multicenter, retrospective cohort study of 62 patients from three institutions who were treated with similar protocols for nonmyeloablative HSCT. AKI was classified according to the Acute Kidney Injury Network criteria. It was shown that 29% of the patients developed AKI in the first 100 days after nonmyeloablative HSCT. The risk factor at baseline for AKI was incomplete HLA-matched transplant (odds ratio (OR) 3.6; 95% confidence interval (CI) 1.1-13.0). Complications such as acute GVHD, veno-occlusive disease of liver and sepsis were also associated with the development of AKI (OR 12.1; 95% CI 2.4-62.4). AKI was significantly associated with mortality (OR=4.7; 95% CI 1.9-11.5). We concluded that AKI is a very common complication in patients with nonmyeloablative HSCT, which is associated with incomplete HLA-matched transplant and complications, and has an important impact on the patients' first year of survival.
机译:急性肾损伤(AKI)是造血SCT(HSCT)患者的常见早期并发症。但是,关于非清髓性HSCT患者中AKI的发生率和危险因素的数据有限。我们对来自三家机构的62例接受了非清髓性HSCT相似治疗方案的患者进行了一项多中心,回顾性队列研究。根据急性肾损伤网络标准对AKI进行分类。结果表明,有29%的患者在非清髓性HSCT后的前100天内出现了AKI。基线时AKI的危险因素是不完全的HLA匹配移植(优势比(OR)3.6; 95%置信区间(CI)1.1-13.0)。急性GVHD,肝静脉闭塞性疾病和败血症等并发症也与AKI的发生有关(OR 12.1; 95%CI 2.4-62.4)。 AKI与死亡率显着相关(OR = 4.7; 95%CI 1.9-11.5)。我们得出的结论是,AKI是非清髓性HSCT患者的非常常见的并发症,与不完全的HLA匹配的移植和并发症相关,并且对患者的第一年生存具有重要影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号